Theravance Biopharma, Inc.
DE ˙ DB ˙ KYG8807B1068
13,60 € ↑0,30 (2,26%)
2026-06-04
CENA AKCJI
SecurityDE:0TB / Theravance Biopharma, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership764,105 shares
Latest Disclosed Value $ 12,401,424
UBS Group AG reports 33.95% increase in ownership of 0TB / Theravance Biopharma, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 764,105 shares of Theravance Biopharma, Inc. (DE:0TB) valued at $10,086,186 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 570,425 shares of Theravance Biopharma, Inc.. This represents a change in shares of 33.95% during the quarter. The current value of the position is $10,391,828 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 764,105 193,680 33.95 12,401 16.20 0.0019
2026-01-29 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 570,425 56,255 10.94 10,673 42.18 0.0017
2025-11-13 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 514,170 117,037 29.47 7,507 71.37 0.0012
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 397,133 -20,488 -4.91 4,380 17.46 0.0008
2025-05-13 2025-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 417,621 243,376 139.67 3,729 127.52 0.0007
2025-02-14 2024-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 174,245 143,488 466.52 1,640 563.56 0.0003
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 30,757 -3,015 -8.93 248 -13.64 0.0001
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 33,772 -25,317 -42.85 286 -46.04 0.0001
2024-05-13 2024-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 59,089 -11,917 -16.78 530 -33.58 0.0001
2024-02-09 2023-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 71,006 17,288 32.18 798 72.35 0.0002
2023-11-09 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 53,718 11,007 25.77 464 4.75 0.0002
2023-08-11 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 42,711 15,987 59.82 442 52.94 0.0001
2023-05-12 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 26,724 18,068 208.73 290 197.94 0.0001
2023-02-08 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 8,656 8,556 8,556.00 97 9,600.00 0.0000
2022-11-10 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 100 -193 -65.87 1 -50.00 0.0000
2022-08-10 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 293 -3,256 -91.74 2 -94.12 0.0000
2022-05-16 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 3,549 1,101 44.98 34 25.93 0.0000
2022-02-14 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 2,448 1,683 220.00 27 350.00 0.0000
2021-11-15 2021-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 765 665 665.00 6 500.00 0.0000
2021-08-13 2021-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 100 -218,938 -99.95 1 -99.98 0.0000
2021-05-12 2021-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 219,038 50,839 30.23 4,471 49.58 0.0015
2021-02-11 2020-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 168,199 85,425 103.20 2,989 144.40 0.0010
2020-11-12 2020-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 82,774 80,249 3,178.18 1,223 2,207.55 0.0005
2020-07-31 2020-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 2,525 -1,953 -43.61 53 -49.04 0.0000
2020-05-01 2020-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 4,478 1,953 77.35 104 60.00 0.0000
2020-02-14 2019-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 2,525 -197,577 -98.74 65 -98.33 0.0000
2019-11-14 2019-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 200,102 192,545 2,547.90 3,898 3,069.11 0.0015
2019-08-14 2019-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 7,557 2,611 52.79 123 9.82 0.0000
2019-05-14 2019-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 4,946 -24,546 -83.23 112 -85.15 0.0000
2019-02-14 2018-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 29,492 23,324 378.15 754 275.12 0.0003
2018-11-14 2018-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 6,168 3,083 99.94 201 187.14 0.0001
2018-08-14 2018-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,085 -1,426 -31.61 70 -35.78 0.0000
2018-05-15 2018-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 4,511 2,117 88.43 109 62.69 0.0000
2018-02-14 2017-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 2,394 -4,825 -66.84 67 -72.87 0.0000
2017-11-14 2017-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 7,219 4,794 197.69 247 157.29 0.0001
2017-11-14 2017-06-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 2,425 2,225 1,112.50 96 1,271.43 0.0000
2017-08-14 2017-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 2,425 96
2017-11-14 2017-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 200 0 0.00 7 16.67 0.0000
2017-05-12 2017-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 200 0 7
2017-02-14 2016-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 200 -3,083 -93.91 6 -94.96 0.0000
2016-11-14 2016-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,283 2,319 240.56 119 466.67 0.0001
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 964 -451 -31.87 21 -19.23 0.0000
2016-05-12 2016-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 1,415 -4,146 -74.55 26 -71.43 0.0000
2016-02-16 2015-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 5,561 5,061 1,012.20 91 1,416.67 0.0001
2015-11-13 2015-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 500 -374 -42.79 6 -50.00 0.0000
2015-08-14 2015-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 874 0 0.00 12 -20.00 0.0000
2015-05-14 2015-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 874 -1,931 -68.84 15 -64.29 0.0000
2015-02-17 2014-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 2,805 2,805 42 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.